Related Experiment Video
Updated: Feb 9, 2026

Orthotopic Mouse Model of Colorectal Cancer
Published on: December 4, 2007
Eicosanoid signaling in carcinogenesis of colorectal cancer
Yuxin Wang1,2, Weicang Wang2, Katherine Z Sanidad2,3
1College of Life Science, Northwest University, Xi'an, Shaanxi, China.
Abstract:
Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer-related death in the USA. It is of practical importance to identify novel therapeutic targets of CRC to develop new anti-cancer drugs and to discover novel biomarkers of CRC to develop new detection methods. Eicosanoids, which are metabolites of polyunsaturated fatty acids produced by cyclooxygenase (COX), lipoxygenase (LOX), and cytochrome P450 (CYP) enzymes, are important lipid-signaling molecules involved in the regulation of inflammation and tumorigenesis. Substantial studies have shown that the profiles of eicosanoids are deregulated in CRC, and the enzymes, metabolites, and receptors in the eicosanoid signaling cascade play critical roles in regulating colonic inflammation and colon tumorigenesis. In this review, we discuss the roles of the COX, LOX, and CYP pathways in the carcinogenesis of CRC.
Insights
Colorectal cancer (CRC) involves deregulated eicosanoid signaling. This review explores how cyclooxygenase (COX), lipoxygenase (LOX), and cytochrome P450 (CYP) pathways impact CRC development, identifying potential therapeutic targets.
Area of Science:
- Biochemistry
- Oncology
- Molecular Biology
Background:
- Colorectal cancer (CRC) is a leading cause of cancer death.
- Identifying novel therapeutic targets and biomarkers for CRC is crucial.
- Eicosanoids, lipid signaling molecules, are implicated in inflammation and tumorigenesis.
Purpose of the Study:
- To review the roles of eicosanoid-producing enzymes in colorectal cancer.
- To discuss the involvement of cyclooxygenase (COX), lipoxygenase (LOX), and cytochrome P450 (CYP) pathways in CRC carcinogenesis.
- To highlight potential therapeutic targets within eicosanoid signaling pathways.
Main Methods:
- Literature review of studies on eicosanoids and CRC.
- Analysis of the roles of COX, LOX, and CYP enzymes in colon cancer development.
- Synthesis of current knowledge on eicosanoid signaling in CRC.
Main Results:
- Eicosanoid profiles are frequently altered in CRC.
- Enzymes, metabolites, and receptors in eicosanoid pathways are critical for colon tumorigenesis.
- COX, LOX, and CYP pathways significantly influence CRC development.
Conclusions:
- The eicosanoid signaling cascade is a key regulator of colonic inflammation and CRC.
- Understanding the roles of COX, LOX, and CYP pathways offers opportunities for novel CRC therapies.
- Targeting eicosanoid pathways may lead to new strategies for CRC prevention and treatment.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Endocrine Signaling
Bacterial Signaling
Yeast Signaling
What is Cell Signaling?
Paracrine Signaling

